# PUMA BIOTECHNOLOGY, INC. (PBYI) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from PUMA BIOTECHNOLOGY, INC.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/PBYI/mda/fy2025/): filed 2026-02-26; accession 0001437749-26-005891 (https://www.sec.gov/Archives/edgar/data/1401667/000143774926005891/pbyi20251231_10k.htm); latest 10-K
- [FY 2024 MD&A](/company/PBYI/mda/fy2024/): filed 2025-02-27; accession 0001437749-25-005496 (https://www.sec.gov/Archives/edgar/data/1401667/000143774925005496/pbyi20241231_10k.htm)
- [FY 2023 MD&A](/company/PBYI/mda/fy2023/): filed 2024-02-29; accession 0001437749-24-006121 (https://www.sec.gov/Archives/edgar/data/1401667/000143774924006121/pbyi20231231_10k.htm)
- [FY 2022 MD&A](/company/PBYI/mda/fy2022/): filed 2023-03-02; accession 0001437749-23-005233 (https://www.sec.gov/Archives/edgar/data/1401667/000143774923005233/pbyi20221231_10k.htm)
- [FY 2021 MD&A](/company/PBYI/mda/fy2021/): filed 2022-03-03; accession 0001437749-22-005164 (https://www.sec.gov/Archives/edgar/data/1401667/000143774922005164/pbyi20211231_10k.htm)

Back to /company/PBYI/